Quantcast
Home » Topics » pfizer inc

FDA approves pneumonia vaccine for adults

(Reuters) – U.S. health regulators approved the expansion of Pfizer Inc’s blockbuster Prevnar vaccine for use in adults 50 and older to fight pneumonia, meningitis and other diseases cause by pneumococcus bacteria. Prevnar 13 is designed to fight 13 forms of a bacterium called Streptococcus pneumoniae, or pneumococcus. Pneumonia caused…

Google+